Health-Related Quality of Life After Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Results From a Multi-institutional Consortium of Prospective Trials-Reference-Cited by-同舟云学术

Health-Related Quality of Life After Stereotactic Body Radiation Therapy for Localized Prostate Cancer: Results From a Multi-institutional Consortium of Prospective Trials

Published:2013-12 Issue:5 Volume:87 Page:939-945
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

King Christopher R.,Collins Sean,Fuller Donald,Wang Pin-Chieh,Kupelian Patrick,Steinberg Michael,Katz Alan

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference25 articles.

1. Hypofractionated versus conventionally fractionated radiotherapy for prostate carcinoma: Final results of phase III randomized trial;Yeoh;Int J Radiat Oncol Biol Phys,2011

2. Acute and late toxicity in a randomized trial of conventional versus hypofractionated three-dimensional conformal radiotherapy for prostate cancer;Arcangeli;Int J Radiat Oncol Biol Phys,2011

3. Randomized trial comparing two fractionation schedules for patients with localized prostate cancer;Lukka;J Clin Oncol,2005

4. Hypofractionated conformal radiotherapy in carcinoma of the prostate: Five-year outcome analysis;Livsey;Int J Radiat Oncol Biol Phys,2003

5. A phase ii trial of arc-based hypofractionated intensity-modulated radiotherapy in localized prostate cancer;Lock;Int J Radiat Oncol Biol Phys,2011

Cited by 166 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Stereotactic Magnetic Resonance–Guided Daily Adaptive Radiation Therapy for Localized Prostate Cancer: Acute and Late Patient-Reported Toxicity Outcomes;Advances in Radiation Oncology;2024-09

2. MULTI-modal radiomics to predict early treatment response from PSA (prostate specific antigen) decline in prostate cancer patients under stereotactic body radiotherapy in MR-Linac;Journal of Radiation Research and Applied Sciences;2024-06

3. Sparing of the Neurovascular Bundles Maintained in the Presence of Realistic Treatment Uncertainties in Hypofractionated Radiotherapy of Prostate Cancer;2024

4. Prostate Cancer;Hypofractionated and Stereotactic Radiation Therapy;2024

5. Stereotactic body radiotherapy with CyberKnife® System for low- and intermediate-risk prostate cancer: clinical outcomes and toxicities of CyPro Trial;Frontiers in Oncology;2023-11-07